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The solubilities of theophylline in , and flu xes through skin 
fro m, isopropyl myristate, octanol, dimethylformamide, 
propylene glycol, ethylene glycol, and formamide have 
been determined experimentally. Values for experimental 
permeability coefficients (Kp) corresponding to the respec-
tive flu xes were determined from, flu x/solubility = Kin 
w hich were then compared with values for the respective 
theoreti cal partition coeffi cients (PC) calculated from the 
known solubility parameters for the vehicles (8v ), theoph-
ylline (8) and skin (8s). There was a good correlation for 
theoretical log PC - 2.52 = experimental log Kp for 
vehicles exhibiting solubility parameters in the range of 
8v = 12-18 (cal/cm ))!. This allows relative flu xes to be 
T he sin gle most important decision that is made in des ignin g top ica l drug delivery sys tems is the choice of the vehicles or formulations that are to be used. In addi ti on to cosmeti c considerations, the choice of the vehicle has a signifi cant impact on the rate at which 
a particular drug is deli vered into and then through the skin , i. e., 
the flu x of the drug [1-4]. T hat is because the solubility of the 
drug in the vehicle is affected by the choice of the type of vehicle 
(functional groups present, IipophiJicity, hydrophilicity, etc.) [5-7] , 
and the rate of delivery of the drug is directl y dependent on the 
Manuscr ipt received October 11 , 1985; accepted for publication Feb-
ruary 10, 1986. 
Partiall y supported by NIH g rant 1 R01 AM33957. 
Reprin t reques ts to Kenneth B. Sloan, Ph.D., Department of Medicinal 
C hem istry, Box J-485 JHMHC, University of Florida, Gainesville, Flor-
ida, U .S. A. 
Abbreviations: 
et : activity 
C: concentration 
8: solubi li ty parametc r 
D: diffusion coefficicnt 
'Y: activity coefficient 
i: drug 
J: flu x 
KI': permeabili ty coeffi cient 
J.L : chemica l potential 
h: membrane thickness 
PC: partition coefficient 
cpo volum e fract ion 
R: gas law constant 
s: sk in 
sat: saturated solution 
T: temperature 
v: vehicle 
V: molar vo lume 
X: mole fra ction concentration 
determined from calculated theoretical partition coeffi-
cients and experimentally determined solubilities in that 
range. For vehicles or mix tures of vehicles exhibiting sol-
ubility param eters in the range of 8v = 8-12 (cal/cm))! 
large increases in flu xes and permeability coefficients, Com-
pared with those predicted from the results in the Ov = 
12-18 (cal/cm))! range, were observed because of vehicle 
effects on the skin caused by the similarity in solubility 
param eters of those vehicles to that of skin. Qualitatively, 
flu xes and permeability coefficients were found to be in-
versely dependent on drug solubility in the vehicles with 
a minimum that corresponded approximately to the point 
where OJ = ov' J Invest D ermatol 87:,244-252, 1986 
solubility of the drug in the vehicle (Ci, equation 2). Gene rally 
it is assu med that if an increase in the solubility of the drug is 
realized, an increase in ra te of delivery or flu x o f the drug and an 
improved clinical effect will result [8,9]. The desired increase in 
solubility of the dru g is usually accomplished by adding va rious 
solubilizers to the vehicle [10] or by changing the relative com-
position of the mi xture of solvents that comprise the vehicle itsel f 
[11,12]. In addi tion , there are also numerous theo retical bases for 
predicting the solubility of a drug in a vehicle so that formulation 
changes designed to increase the solubility of the drug can be 
made on a rational basis [6,13]. 
However, this relativel y simple relationship between the sol-
ubility of the dru g in its vehicle and the flu x of the drug from 
that vehicle apparently does not always hold. Higuchi [14] has 
predicted, and it has been shown [8, 12, 15], that dru g-so lubilizin g 
capacity of the vehicle in excess of that needed to dissolve the 
desired dose of dru g can actually lead to a decrease in the rate of 
dru g delivery from that vehicle. When the equation for flu x is 
expanded (equation 2) the delicate balance between partition coef-
fi cient and drug solubility in the vehicl e becomes apparent; as the 
drug solubility in the vehicle goes up, the partition coefficient 
goes down, the 2 effects tend to cancel each other [2,11], and to 
a first approximation the effect on flu x is indeterminate. On the 
other hand , when the flu x of a drug from a particular vehicle is 
divided by the solubility of the drug in that vehicle, the result is 
the permeability coefficient (eq uati on 3) which is dependent onl y 
on the partition coeffi cient of the drug between that vehicle and 
skin. The experimental solubility of a drug in a particular vehicle 
ca n be obtained fairly easily [6]. so the relative flu x of the drug 
from that vehicle compared with another vehicle would be readil y 
ava ilable if there were theoretical bases for predicting the relative 
partition coefficients for that dru g between the respective vehicles 
and skin . Because the ability to predict, at least qu alitatively, the 
effect of changes in vehicles on flu x is so important to clinical 
in vestigators and drug formul ators, there is definitel y a need for 
sllch theoretical bases. The pu rpose of this paper, then is to pro-
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vide the theoretical bases that will allow those predictions to be 
made and to provide in vitro experimental data- diffusion cells-
to support the theoretical conclusions. 
THEORET~ALBACKGROUND 
The steady-state flux of drug i from a vehicle through skin is 
given by the general expression for passive diffusion derived from 
Fick's laws [1-3] : 
(1) 
J; 'v = (Pq·V)Ci(D1/h,) = (q/CnCi(D1/h,) (2) 
where J1' v is the flux of drug i from a particular vehicle; K~:r is 
the permeability coefficient; Pq·v is the partition coefficient for 
the distribution of drug i between a particular vehicle and skin 
which for ideal solutions is equal to the concentration of the drug 
i in the skin (Cn divided by the concentration of the drug i in 
the vehicle (Cn; D1 is the diffusion coefficient for the drug i in 
the skin; and h, is the thickness of the membrane which in this 
case is skin . The product of the partition coefficient (pq.V) and 
the diffusion coefficient (Dn divided by the thickness of the skin 
(h,) is the permeability coefficient (K~·.';', equation 3). Furthermore, 
if the diffusion coefficient for drug i in a particular type of mem-
brane is independent of the vehicle used (assuming that the ve-
hicles do not change the properties of the membrane in different 
ways or to different degrees or that they do not codiffuse with 
drug i [1,16]) and, within the limits of biologic variability , the 
thicknesses of the membranes are constant, then the diffusion 
coefficient of drug i (Dn divided by the thickness of the skin (h,) 
is a constant (Pl, equation 4) for that series of experiments. How-
ever, D 1 will vary with the concentration of drug i in the skin 
and the temperature. 
K~·.i = (Pq·V)D1/h, (3) 
P1 = D1/h, = constant. (4) 
The thermodynamic driving force for the partitioning of drug 
i between 2 phases depends on the difference between the chemical 
potentials (J.tj) of drug i in the 2 phases [17] . At equilibrium ~his 
difference is equal to zero. For nonideal solutions the potentials 
are dependent on the activities of dru g i [ai(n)] in each of the 2 
phases (rather than the concentrations) in equation 5 where R IS 
the gas law constant, T is the temperature in degrees Kelv1l1 , and 
ILr is the standard state chemical potential of drug i based on the 
mole fraction (Xj) as the concentration scale. Since fLP· v(n) IS 111-
dependent of the nature of the solvent (vehicle) on the mole 
fraction scale, fLP·v( l ) = fLP· v(2). The result, at equilibrium for the 
partitioning of drug i between 2 vehicles to form saturated non-
ideal solutions, is: 
fLP· v( l) - fLP ·v(2) = RT In [ai(2)sa'/ai(')' al] = O. (5) 
Since RT In [ai(2),a'/a i( I),.,] has to equal zero, [ai(2)s"/a1'(I)s.,] has 
to equal one and a1'(I)sa, = a i(2),., [18-19]; but Xi(')sat f. X i(2)s.,. 
Since ai(n) = X1' (n )'Y1'(I1 ) [17], where 1'1' (11 ) = the activity coeffici ent 
of drug i in vehicle n , In a i(n) = In Xi(n) + In 'Y1'(n). But, since 
a r (l )s3t = ll' i(2)S3t: 
In X1' ( I )50t + In 'Yi( ,),·t = In X1'(2)s.t + In 'Yi (2)50 ' (6) 
and 
In Xi(2),. , - In Xi(I)50' In 'Yi(')'" - In 'Yi(2),., 
or 
In [Xi(2)" '/Xi(I ),a,] = In [Yi(I),a,/yv(2),.,;]. (7) 
Equation 7 is also equal to In PCi(2. 1),. , [11,20] or In p q .v(s.,) 
w here v(2) = sand v(l) = v(sat) . ' . 
The value for the natural logarithm of the activity coeffiCient 
of drug i in any particular vehicle (In yr(n») can be determined by 
considering the intermolecular forces of attraction that must be 
overcome in removing a molecule fr0111 the solute (solid phase) 
and depositing it in the solvent or vehicle [21] . So that: 
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(8) 
where ov(n) is the solubility para m eter of the vehicle, OJ is the 
solubility parameter of the drug i, Vj is the molar volume of drug 
i, and cf>v(n) is the volume fra ction of the solvent. Fo r dilute so-
lutions cf>~(n) approaches one. Substitution of the identities for In 
Yi(n) from equation 8 into equations 6 and 7 gives [22,23]: 
In PCi(2. 1)' al = In Yi(l) - In Yi(2) 
[(OJ - ov(lyVjcf>~(I /RT] 
- [(OJ - ov (2)fVjcf>~(2/RT] 
[(OJ - ov( l)f - (OJ - ovd2]V;/RT 
or 
log PCf·v(n)sat = ([OJ - Ov(n)]2 - [OJ - o,F) V;/2.3 RT (9) 
where v(l) = v(n) and v(2) = s. 
From equations 3 and 4 it can be seen that the experimentally 
determined permeability coefficient K~·.Y is directly dependent on 
only one variable-the partition coeffi cient PC;· v. Thus, the ex-
perimentally determined K~·.y(n ), .t should be directl y proportional 
to the product of the theoretically determined PC1· v(n)s.t and a 
constant. 
EXPERIMENTAL PROCEDURES 
The theophylline was obtained from Sigma St. Louis, Missouri. 
The isopropyl myristate w as obtained from Givaudan Corp. , 
Clifton , N ew J ersey. The remaining vehicles were obtained from 
Aldrich; they were all >99% pure and were used as received . The 
diffusion cells w ere Franz type cells (2.5 cm in diam eter, 4.9 cm2 
= area, 20 ml receptor phase volume) w hich were obtained from 
Crown Glass of Somerville, N ew Jersey. A Fisher model 80 cir-
culating water bath was used to maintain the temperature in the 
water-j acketed receptor phases. Ultraviolet spectra were obtained 
using a Varian Cary 210 spectrophotometer. The mice were fe-
male hairless mice (SKH-hr-1) obtained from Temple Univers ity 
Skin and Cancer Hospital and weighed 20-22 g. The pH meter 
was a Markson selectromark analyzer. 
Solubility Determination The solubility of theoph ylline in 
each vehicle was determined in triplicate (SD ± 3%) by stirring 
an excess of theophylline (200 m g of theophylline/3 ml of vehicle) 
with a magnetic stirrer for 48 h at room temperature (23 ± 1°C) 
in sealed fl asks which were thermally insulated from the stirrer 
(Table I) . The 48 h was sufficient to ensure that the solutions 
were saturated [6 ,12] . The suspensions that resulted were filtered 
by g ravity through Whatman no . 1 (qualitative) filter paper [24]. 
Samples of the filtrates were immediately taken and diluted with 
methanol. The concentrations of the theophylline in the methanol 
solutions were measured at 270 nm (e = 1.02 X 104 liters/m ol). 
Diffusion Determination The suspensions of theophylline that 
were used in the diffusion experiments were prepared by stirring 
200 m g of theophylline in 3 ml of vehicle for 48 h at room 
temperature before th ey were applied to the m ouse skins. Sus-
pensions were used because the conclUSIOns reached 111 the the-
Table I. Calculated Partition Coefficients [pq.v(n)] and 
Experimentally Determined Solubilities of Theophylline 
in the Vehicles 
Solubility Mole Fraction 
Vehicle log PCf·v(n) ' (mg/cm3) Solubility X 103 
Isopropyl myristate 1.12 0.062 0.109 
Octanol -0.18 1. 70 1.49 
Dimethylformamide -0.98 34.561' 14.8 
Propylene glycol -1.22 8.07 3. 30 
Ethylene glycol - 0.92 7.40 2.30 
Formamide -0.06 1.57 0.346 
'Determined from equation 9 using T = 30soK. Il; = 14.0 (callcmJ)1 fro m Table 
V. ll'ln) from Tables V and VI. V; = 110 cmJ/ mol from Table V. R = 1. 98 cal/degree 
mol. and Il, = 10.0 (cal/cn],')1 (see [31]). 
' Literature va lue of 36.3 mg/cm' at 25°C (sec [32]). 
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o reti ca l part were based on th e maintenance of saturated solutions 
in th e do no r phase . D uring the ex perim ent, as d ru g in solution 
partitions in to the di ffuses through the skin , mo re o f the sus-
pended so lid w ill dissolve in th e vehicle to maintain the sa turated 
solu tion. The recepto r phases o f the diffusion ce lls were main-
tained at 32°C-the approxima te temperature of th e skin-with 
a circulatin g wa ter bath durin g th e enti re experiment . T he room 
temperature was 23 ± 1°C durin g diffusio n determin atio ns. The 
mice were sacrifi ced by cervica l disloca tio n. Wh ole-thickn ess in-
tact skin s were removed using blunt di ssectio n to separate th e 
skin s fro m the underl ying fascia. T he skins w ere immedi ately 
pl aced in th e diffusion cell s in contact w ith the receptor phase, 
which was pH 7.3 (at 32°C) phos phate bu ffer (0 .05 M , io ni c 
streng th = 0. 11 ) containing 0. 1 v/v o f 36% aq ueo us fo rm alde-
hyde as a preserva ti ve. T he skins were held in pl ace with rubber 
O-rin gs and the 2 halves of th e cells were hel d together w ith 
clam ps . T he mouse skins were kept in contac t w ith the bu ffer 
fo r 24 h to allo w any wa ter-soluble UV-a bso rbin g materials to 
leach fro m th e skins; the recepto r phase was changed 3 times 
durin g this period . After 24 h, 0. 5 ml aliquo ts o f a theoph ylline 
suspension in a particul ar vehicle w ere appli ed to the dono r side 
o f each o f 3 skin s using an E ppendo rf di gital pipetter . The sus-
pensions were kept well stirred whil e the aliquots were with-
drawn. T he amount of theophylline applied was consistentl y ± 5% 
of the th eoretica l amo un t as determin ed in a separate experiment 
w here aliquo ts of the suspensio ns were taken under the sa me 
cond itio ns and analyzed by UV spectrosco py. Usuall y 2 vehicles 
were tes ted at a time to give a to tal of 6 diffusio n cells being run 
in an ex perim ent. Samples o f the recepto r phases (3 ml) fo r UV 
analysis were taken at 3, 6, 9, 12, 18, 21, 24, 30, 36, and 48 h 
after th e suspensions were applied . The recepto r phases were 
replenished w ith 3 ml o f fresh pH 7.3 phosphate bu ffer after each 
sa mple w as taken. Thus, the analysis of each subsequent sample 
had to be corrected fo r all th e prev ious sa mples that had been 
remo ved for analys is. Thi s resulted in addin g 15% of th e amount 
of theo ph ylline in each previo us sa mpl e to the amount o f the-
oph ylline in th e sa mple bein g analyzed . 
At the end of this 48 h th e do no r phases were was hed 3 tim es 
with 10 ml of methano l, taki ng ca re to remove all solid theoph-
ylline particles and to keep the ti me of contact between the skin 
and th e meth anol to a minimum «3 min tota l). T he meth ano l 
was hes fro m each cell were co mbin ed and analyzed by UV spec-
trosco py. T he receptor phases were changed and th e skin s were 
then kept in contact with fres h buffer fo r 23 h to all ow any res idual 
theoph ylline in th e skins to leach o ut . At th e end of23 h, sa mples 
(3 ml) were remo ved and were analyzed by UV spectroscopy; 
th e rece pto r phases were changed aga in . The to tal amount o f 
theoph ylline that diffused , th at was washed o ff the dono r phase, 
and th at leached from the skin s durin g the las t 23-h period ac-
co unted fo r 93 ± 5% of th e theoph ylline that had been orig inall y 
applied . Afte r another 1 h o f co ntact between the skin s and the 
fresh recepto r phascs, the recepto r phases werc analyzed by UV 
spcctrosco py to assure th at no mo re th eoph ylline was leachin g 
fro m th e sk ins into the recepto r phases. 
T hen, in o rder to assess any irrevcrsibl e effec ts of theo ph ylline 
in the va rio us vehicles o n perm ea bility, a second appli ca tio n of 
th eoph yllinc in pro pylene g lyco l to the sk ins w as perfo rm ed. 
Aliquo ts (0 .5 m l) of a th eoph yllinc suspcnsio n in pro pylene g lyco l 
(400 mg/6 ml) we re applied to all 6 cell s and sa mples w ere w ith-
draw n fro m the rccepto r phasc after 3. 6, 12, 24, and 48 h fo r 
analys is by UV spectroscopy. Contro l ex perim ents were run in 
w hi ch the mo use skin s wcre kept in contact w ith the pH 7. 3 
phosphate bu ffe r rece pto r phase fo r 2 and 120 h before bein g 
trea ted w ith 0.5-ml aliquo ts o f a th eo ph ylline suspension in pro-
pylene g lycol (400 mg/6 ml). T here we re no signi fica nt di ffercnces 
(p < 0.5) between the Au xes fo r those experim ents (1.29 ± 0.64 
x 10 - 3 mg/c m2 h after 2 h, 1.41 ± 0.09 x 10 - 3 mg/cll1 2 h after 
120 h) an d fo r the protoco l in w hich there was 24-h contac t w ith 
the receptor phase before appli ca tio n o f th eoph ylline in propylene 
g lyco l (1. 54 ± 0.3 1 X 10 - 3 mg/cm2 h). 
T H E JO URNAL OF INV ESTIGAT IV E DERMATO LOGY 
Valucs fo r Au x in alJ cases were o btained by plotting the cu-
mulati vc mg o f thcophyllinc measurcd in thc receptor phase against 
time in hours (fo r exa mple see Fig 1). The values of flu x fo r the 
first phase o f the diffu sion o f theoph ylline in the vario us vehicles 
were usually o btaincd over thc period o f 3- 9 to 3-18 h. The 
values o f Aux fo r the sccond phase were th en obtained over the 
remaining time. Fo r thc sccond applicatio n of thcophyllinc, only 
one diffusion phasc w as observed (fo r cxample sec Fi g 2). In all 
cases linear regression analysis was used to obtain the slo pes fo r 
the plo ts o f mg again st h, and co rrelation coeffi cients were a t 
least r = 0.99 . Fluxes were obtained by dividin g the abo ve slo pes 
by the area o f the di ffu sion cell (4.9 cm2), and the permeability 
coeffi cients were then obtained by dividing th e Auxes (mg/cm 2 
h) by the correspo nd ing so lubility o f theo ph ylline in that so lvent 
(mg/cm3 o f solution) (Ta bles II - I V). 
Calculated Solubility Parameters The ca lculated solubility 
parameters were obtained using the method o f Fedo rs [25,26] as 
illustrated by Martin et al [6'1. The results fo r theoph ylline and 
isopro pyl m yristate are g iven in T able V. 
Microscopic Examination of Skins In a separate ex perim ent, 
6 mi ce were sacrifi ced, their skin s w ere placed in diffusion cells 
in contac t w ith pH 7.3 phosphate buffer fo r 24 h, and then 5 w ere 
trea ted with suspensions o f th eo ph ylline in different vehicles. The 
vehicl es used were iso propyl m yristate, octano l, dimethyl-
fo rm amidc, pro pylene g lycol, and form amide. The sixth skin was 
not trea ted w ith any vehicle. T he pro toco l fo r the anal yses of 
theoph ylline that diffused was th e sa me as in the diffusio n ex-
perim en ts but at the end o f 48 h the skin s were rem oved fro m 
the cell s, washed w ith distilled wa ter, and patted dry on paper 
towels. T hen, six 3-mm punch bio psies were taken of each skin 






















Figure 1. Plots of cumulative mg of theoph ylline diffused through hair-
less mouse skins from eth ylene glycol suspensions vs time. The dashed 
lili es and OpC/l s),lIIbols represent the data from indi vidual diffusion cells 
while the solidlill c and so lid circles represent the average of the 3 cells. 
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Figure 2. Plots of cumulati ve mg of theophylline diffused through hair-
less mouse skins from propylene glycol suspensions vs time after the skins 
had been pretreated with theoph ylline/eth ylene glycol. T he dashed lilies 
and opw sYlllbols represent the data from individual diffusion cells while 
the solid /ill e and solid circles represent the average of the 3 cells. 
a mination by light microscop y. No sig nificant differences could 
b e seen between the sectio ns o f skin which had no t been trea ted 
with a vehicle and those that had. The rates of diffusion o f the-
ophylline through these skins w ere within the standard deviations 
for the rates of diffusion of theophylline obtained in the diffusion 
d etermination expe riments (see T able Ill ). 
RESULTS 
The mole fra ction solubilities o f theoph ylline (solutc) in the ve-
hicles or solvents (Table I) fit the expected relationship between 
the peak solubility of the solute and the coincidence of the sol-
ubility parameter of the solute with th at o f the solvent o r vehicle 
(T able VI) [27,28). This relationship has been used to determine 
the solubility param eter for so lutes (Oi) and is frequently referred 
to as the peak solubility m ethod [6) fo r m aking such determj-
nations . The reliability o f the method is not always good because 
of the variable values of Oi that can be obtained when polar sol-
vents or mixtures of polar solvents are used [7) . However, a 
solubility parameter of 14 (cal/cm 3)1 for theophylline had been 
d etermined previously using the peak solubility m ethod [32). 
Also, as seen in T able I, the peak solubility for theophylline, fo r 
Table II. Experimentall y D etermin ed Fluxes and 
Permeability C oeffi cients [K~J(I1) ] fo r the First Phase o f the 
Diffusion of Theoph ylline Throug h H airless M o use Skin from 
the Vehicles" 
Flux 01' v(Il») K s.y(n) "x" p.1 
± SD x 103 ± SD x 103 Intercept 
Vehicle (mg/cm2 h) (cm/h) (h) 
Isopropyl m yristate 16. 1 ± 4.4 260 ± 74 3.0 
Octanol 110.0 65 2.2 
Dimethylformamideb 
Propylene glycol 1.08 ± 0. 38 0. 134 ± 0.047 5.1 
Ethylene glycol 1.1 6 ± 0.44 0.157 ± 0.059 2. 2 
Formamide 1. 92 ± 0.40 1.23 ± 0.26 2.2 
' n = 3 except octano l fo r w hich 11 = I . 
' Only one phase fo r the diffusion o f th eophy lline fro m dimeth yl fo rm am ide was 
o bserved . 
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Table III . Experim entall y D etermined Flu xes and 
Permeability Coeffi cients [K~·.y(I1 ) ] fo r th e Stead y- State (Second) 
Ph ase o f the Diffusio n o f T heoph yllin e Thro ug h H airless 
M o use Skin fro m th e V ehicl es" 
Vehicle 
1. Isopropyl myristate 
2. Octanol 
3. Dimethylform amide 
4. Propylene glycol 
5. Eth ylene glycol 
6. Formamide 
"n = 3. 
Flu x Ul·' (I1)] 
± SO X lOJ 
(mg/ c ll1 ~ h)" 
41.2 ± 3.7 
547.0 ± 146.0 
17.0 ± 4.0 
1. 54 ± 0.3 1 
1.94 ± 0.72 
3.69 ± 0.25 
K !>·y(n) 
p, ' 
± SD x 103 
(cm/h)' 
660.0 ± 6 1. 0 
320.0 ± 86.0 
0.49 ± 0. 12 
0. 19 ± 0.04 
0.26 ± 0.1 0 









''The Au x of theoph ytline fro m vehicle I was sig ni fica ntl y di O-ercnt co mpared w ith 
th at fro m vehi cle :\ (1' < 0.00 1). vehi cle 3 co mpared w ith vchicle 4 (1' < 0 .0025). 
and veh icle 5 co m pared wi th vehicle 6 (p < 0.0 1). 
'The permea bility coefficient fo r the d iffusio n of t heo ph ytlinc fro m vehicle I was 
sign ifi cantl y d iffe rent co m pa red w ith that fro m vehicle 2 (1' < 0 .0025) and veh icle 
:\ com pared with vehicle 4 (p < 0.0 1) w hil e vehicle 4 ",os m arg in atl y d iffe relH 
com pa red wi th vehicl e 5 (1' < 0.3). 
which a solubility param eter o f14 .0 (cal/cm 3)1 had been calculated 
in T able V , w o uld probabl y be o btained fo r a solvent exhibiting 
a solubility para meter between th at of d im ethylform amide 
[ov = 12. 1 (cal/cm 3)!] and pro pylene glycol [0" = 14.8 (cal/cm 3)'). 
Thus, the use of a solubility parameter for theophylline o f abo ut 
14 (cal/ cm 3)! to calculate theoretical PC is reasonabl e based on 
the solubilities o f theophylline determined here and previously 
[32), and theoreticaloi determined from group contributions [25,26) 
(Table V) . 
The solubilities of theo ph yllitie in p ropylen e g lycol and iso-
pro pyl m yristate repo rted in T able I are lo w er th an those pre-
vio usl y repo rted [24) . This is pro bably due to th e fa ct that son-
ica tio n was no t used this tim e but was used previo usly. Soni ca tio n 
o f sa mples of suspensio ns causes the sa mples to ge t ho t and hence 
in crease the solubili ty of the solute above its solubility at roo m 
temperature (in this case). As the solutio n cools so m e of th e so lute 
crys tallizes, but its crys tal fo rm can diff~ r fro m solven t to solvent. 
Thus, th e solubility m easured can be that o f a different cr ys tal 
fo rm fro m each solvent. 
A plo t o f theoretical log PCf· v(I1) fro m T able I aga inst 0 " (11 ) from 
T able VI is shown in Fig 3 as th e solid line where the axis fo r 
th e parabo la is at 0 ,,(11 ) = 14.0 (cal/cm 3)!. Also in the sa m e figure 
the data for the experim ental permeabiJity constants [log K;;.r(I1»), 
which are g iven in Tables II and Ill , are plotted again st the sol-
ubility parameters of the solvents [S"(I1»)' If the assumptio ns abou t 
the solvent not causing any changes in the diffusio n coeffi cient 
are applicable [1 ,16) and if the theoretical log Pq·v(ll) valu es w hich 
are calculated fro m regular solutio n theo ry realistically describe 
the partitioning process, the differen ce between the calcul ated 
th eoretical log PC1· v(ll) and the experim entall y determined log 
Table IV. E ffec t o f Pretrea tment of H airl ess M o use Skin 
w ith Theophylline/Vehicle o n the Diffusio n of Theoph ylline 
from Pro pylene Gl ycol" 
Flux ± SD x 103 "X" Intercept 
Vehicle (mg/cm2 h) (h) 
I. Isopropyl myristate 108.0 ± 17 0.5 
2. Octanol 465 .0 ± 195 0.0 
3. Dimethylform amide 4.6 ± 1.3" 0.5 
4. Propylene glycol 5.8 ± 1.6b 1. 5 
5. Ethylene glycol 5.1 ± 1.0" 2.2 
6. Formamidc 8. 1 ± 3.5/0 0.7 
. I n = 3. 
'T he Au x fro m vehicle 6 was onl y m arginall y differen t from vehicles 5 (p < 0.3). 
4 (1' < 004). o r 3 (1' < 0.2) w hile the flu x fro m vehicle 3 was indis ti nguishab le fro l11 
vehicle 5 and o nl y margin ally di ffere nt fro m vehicle 4 (p < 0.4). 
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Table V. Group Contribution Method for Calculatin g M olar Volume and Solubility Parameters of Theophylline and Isopropyl 
Myristate [25,26]. 
Doe; Dov; 
Atom or Group Number of Groups (cal/mol) (cm" / mol) 
Theopl,yllil/e 
C=O 2 4150 X 2 = 8300 10.8 X 2 = 21.6 
N 2 1000 X 2 = 2000 -9.0x2= - 18.0 
NH I 2000 4.5 
N= I 2800 5.0 
CH) 2 1125 X 2 = 2250 33.5 X 2 = 67.0 
CH= 1 1030 13.5 
C= 2 1030 X 2 = 2060 -5.5 X 2 = - 11.0 
Double bond 2 400x2=800 -2.2 X 2 = -4.4 
Ring closure 2 250xQ=500 16.0 X 2 = 32.0 
LDoc; = 21,740 LDov; = 11 0.2 






K~.r(n) shou ld be a constant that co rresponds to equation 4 (i. e. , 
D Uhs). Excluding for the moment the log K~x(n) values for the 
delivery of theophylline from isopropylmyristate and octanol on 
the basis of the effect of those vehicles on skin (Table IV), the 
average difference between the other experimental log K~.r(n) val-
ues (steady-state phase, Table III) and their corresponding the-
oretical log pq.v(n) values is - 2.52 ± 0.14. Is this a reasonable 
value? Ifit is assumed that the thickness of the stratum corneum 
provides the main resistance to penetration by polar solutes ' and 
that its thickness is about 0.001 cm [3], then the corresponding 
diffusion coefficient for theophylline through skin (DO is 8.3 X 
10- 10 cm2 /s . This value is in the expected range of values for a 
diffusion coefficient for a molecule such as theophylline [33]. So 
the value of 2.52 for the difference between the theoretical log 
PC and experimental log K,> is a reasonable one, but the most 
important outcome is that it is a relatively constant value for those 
vehicles that do not appreciably affec t the skin (see Table IV). 
Thus, excluding the data for isopropylmyristate and octanol, the 
preyious assumptions about sol:vent effects on D1 and the appli-
cability of regular solution theory to calculate theoretical PC ap-
pear to be reasonable. 
T h'e dashed line in Fig 3 represents those theoretical values for 
log K~.r(n) calculated from the theoretical log PCf·v(n) - 2.52. Not 












































"Handbook of Chemistry and Physics, 52d cd. Edited by RC Weast . The C hemica l 
Rubber Co., C leveland , Ohio, 1972. 
' Mo lar volume is equal to the molecular weight divided by the density. 
'Sec 1391. . 
"Sec Table V. 
11 25 X 3 = 3,375 
1180 X 12 = 14,1 60 
820 
4,300 
LDoe; = 22,655 
0; = (LDoe;/LDov;)1 
33.5 X 3 = 100.5 
16.1 X 12 = 193.2 
-1.0 
18.0 
LDov; = 310.7 
(22,655/310.7)1 = 8.5 (ca l/cm3)! 
onl y do the experimenta l va'lues for log K~·.r(n) obtai ned from th e 
steady-state fluxes of theophylline from formamide, ethy lene g ly-
col, propylene glycol , and dimethylformamide approximate this 
theoretical dashed line, but so do the experimental' lo g K~.i(n) 
values for the first phase of the diffusion processes. The K~.i(n) 
va lues from this first phase are much less accurate than those 
obtained during the steady-state portion of the diffusion process 
because they 'cou ld only be obtained from a curved portion of 
the plot of cumul ati ve mg against time in many cases. However, 

















Figure 3. A plot of theoretical log PCl'v(n) (so lid IiI/e) from Table I vs 
ov(,,) and theoretical log K p(") [log per·v(,,) - 2.521 (dashed IiI/ e) vs ov(,,) , 
including the value's for the first phase (so lid circle) and the values for the 
steady-state second phase (opel/ circle) of the experimentally determined 
log K~.1 ("). 
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vehicl es appa rentl y behave in the same way during this clin ica ll y 
more relevant time period as they do in the latter time period 
when steady-state conditi ons o btai n. 
The data for the experim ental permeability coefficients for the 
diffusion of theophylline from isopropy l m yristate and octanol 
(Tables II, Ill; Fig 3) do not fit the trend that the other 4 vehicles 
set. The important point to note is that both these vehicl es exhibit 
solubility parameters close to the va lue of the so lu bility parameter 
[approximately 10 (cal/cm3)!] determined for porcin e skin [31]; 
and that the permea bility coefficient fo r the vehicle with the next 
closest so lubility parameter to that taken for sk in after octanol 
and isopropyl myristate-dimethylformam ide-also lies above 
the dashed line in Fig 3. The trend appears to be that the closer 
the va lue of the so lubil ity parameter of the vehicle is to that of 
the membrane, the greater the deviation from the theoretical par-
tition coefficient and hence the predicted Au x . 
. The va lues for the experimental permeability coefficients 
[K:;.Y(")] for th e steady-state diffusion in Table III are all ig nifi-
cantl y different from each othe~ except when the va lues of 
K~·.i ( " ) for propylene glyco l and ethylene glyco l are co mpared. 
Similarly , the Auxes []t.,, (,,)] in Table III for the steady state dif-
fusion of th eop hylline are all sign ifi ca ntl y different from each 
other except when the values of j t·"(") for propylene g lycol and 
e thylen e g lyco l are compared. Si milar tl:ends in differences be-
tween Auxes and between permeability coefficients for the first 
phases of the diffusion of theophylline from th e different vehicles 
can be seen in Table II. 
There is one point that needs clarification in Tables II and III. 
There is only an n va lue of 1 for the first phase of the diffusion 
of theophylline from octan o l. In that case the data from 2 diffusion 
cell s showed only 1 phase for the diffusion process while data 
fw m th e third diffusion cell showed 2 definite phases. The steady-
state Aux for the second phase of the third diffusion cell was 
included in the data from the first 2 diffusion cells for the ca l-
culation of the average Aux and permeabi lity coefficient (Table 
III), but the intercept (h) is onl y the average from the first 2 
diffusion cells. 
In order to assess the reversibility of the ~ffect of the various 
vehicles on the resistance of skin to diffusion, after the initial 
treatment of the sk ins in the diffusion cells with theophylline in 
different vehicles, the sk ins were all then treated w ith a common 
so lute/sorvent com bination: theophylline / propylene glyco l. The 
effect of time from sacrifice of the mi ce to appli cation of so l-
ute/solvent on the rate of diffusion of theophylline from pro-
pylene g lycol through mouse sk in was not a factor (see experi-
mental) in these experiments. The meth ano l wash between the 
first and second appl ications was determined to have onl y a mar-
ginal effect on the Au x (2.4 ± 0.4 x 10 - 3 mg/cm 2 h, n = 3 vs 
1.5 ± 0.3 x 10 - 3 mg/cm 2 h from Table III ). The Auxes of 
theophylline from propylene glycol through skins that had been 
pretreated with ' theophylline in isopropyl m yristate or octano l 
were 20-80 tim es g reater, respectively, than those pre~reated with 
theophylline in the other 4 vehicles (Table IV). Because theoph-
y lline does not exert a signifi cant effect on the subseq uent re-
sistance of the skins to diffusion (the rate of diffusion of the-
ophylline/propylene g lyco l after an initial treatment with 
theophylline/propy lene glycol, formam ide, eth ylene glyco l, or 
dimethylformamide was increased by onl y 3 times), the cause of 
this altered rate of diffusion of theophylline from propy lene glycol 
must have been the pretreatment with octanol and isopropylmyr-
istate. This effect of octanol on diffusion has been observed pre-
viously [34J , but in that instance the increase in Aux was reversible 
w hile in this instance that does not seem to be the case. 
DISCUSSION 
The process of partitioning of drugs o r chemica ls into sk in from 
vehicles and their subseq uent diffusion through the skin is im-
portant clini ca lly and toxico logicall y, so that the ability to predict, 
at least qualitatively, the effect of vehicles o n the rate at which 
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those drugs or chemicals diffuse t!1rou gh skin has long been a 
goal of research in the area. To a first approximatio n, rate or Au x 
is dependent on 2 variables: the partition coefficient and the con-
centration of the drug or chemica l in the vehicle [1 ,15] . The 
concen tration of the drug in the vehicle can be determined ex-
perimentally but an accurate and approp riate partition coefficient 
is virtually impossib le to o btain experi mentally beca use it depends 
directly on the concentration of the drug in the skin, and that 
concen tration should be determined under conditi ons similar to 
those that obtain in the in vivo (clinical) or in vitro (diffusion 
cell) si tuations. T he concentration of a drug in the skin obtained 
from partitioning of the dru g between a sa mple of skin and the 
vehicle is difficult to determine because of the different degrees 
of changes in hydration and other physical-chemical properties 
of the skin that would result from ' soaking sa mples of skin in 
different types of vehicles for extended periods of time [35] . 
In order to overcome this pro blem, so that the effects of vehicles 
on Au x could be predicted, a number of theoretical bases have 
been developed for considerin g diffusion under experimental con-
ditions where the Aux is no longer dependent on variations in the 
concentratio n of the dru g in the skin (or m o re accurately th e 
thermodynamic ac tivities of the dru g in the skin since we are 
dea ling with no nideal solutions) . The best known of these ap-
proaches is the one o rigin ally proposed by Higuchi [14], and 
verified by Flynn and Smith [121. In this approach the partition 
coefficient is defined as the ratio of the activity coefficient of the 
drug in the vehicle to the activity coefficient of the drug in the 
skin (see eq uation 7). Then, by substituting that identity and the 
ratio of the activity of the drug in the vehicle ~o the activity 
coefficient of the drug in the vehicle for the concentration of the 
drug in the vehicle (Ci = ai / ),1') into the eq uation for Aux (equa-
tion 2) an eq uation results which defines Aux as follows: 
J1' V = (ai / )'O(D1/h,) (10) 
If the Auxes of drug i from sa turated solutions of drug i in different 
vehicles are compared, there should be no differences in the Auxes 
[i .e. , j 1· v ( ! ) = ]1" v(2) = j 1'''('') = constant] because D1/hs = a constant 
(equation 4) and Aux is directly dependent on the activi ty of the 
drug i in the vehicle for which ai(l )( 1) = ai(2)(2) at saturation (see 
eq uation 5). The term "thermodynamic control " has been used 
[1 6] to describe the above conditions where the rate of diffusion 
is theoretically determined by the th ermodynamic activity of the 
drug in the vehicle. 
Flynn and Smith [12] have shown that under the conditions of 
thermodynamic control the Auxes of p-aminoacetophenone from 
sa turated solutions of mi xtures of propylene glycol and water 
were constant; and Woodford and Barry [1 6J have shown that 
under the conditions of thermod ynamic con trol the thermody-
nam ic activity of stero ids correlated well with the bioavailability 
of th e steroids . However, there are man y other instances where 
application of thermodynamic control does not lead to equal Auxes 
of the sa me drug from different vehicles or different compositions 
of vehicles. Ostrenga et al [8] have shown for the delivery of 
Auocinolone acetonide from propylene glycol-wa ter mixtures that 
the maxim um Aux and biologic response was obtained for a ve-
hicle which had only sufficient so lubiIizipg ability to just com-
pletely dissolve a fixed concentration of the drug and that the flux 
and the biologic response deereased in intensity if the solubi lizing 
ability of the vehicle was less, i. c. , a saturated solution of the 
drug in the vehicl e still o btained but not all of the same fixed 
concentration of the dru g had dissolved. Similarly, Cooper [36] 
has shown that the Auxes of salicyli c acid from sa turated solutions 
of ethylene glycol, its hOl11ol ogues or analogues, are different for 
the different vehicles or mixtures of vehicles . Thus, the estab-
lishment of conditions where thermodynamic control is main-
tained does not ensure predictable results from diffusion exper-
iments. This may be due to the fact that the effect of 1/ )'[ was 
not considered in the theoretical treatment. 
On the other hand, instead of trying to experimentally deter-
mine partition coefficients or developing theoretical bases for ig-
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noring th em , a third alternative is to calculate partition coefficients 
from theoretical bases. A number of different methods exist for 
calculating tQe partition coefficient for the distribution of a drug 
between water and a wa ter-immiscible solven t (which serves as ' 
a model for the biologic membrane-usuall y octanol), based on 
fragment con~tants for the various functiona l groups in the drugs 
[37.38). However, these methods ;I re primarily useful for com-
p'aring differen~ drugs in one pair of solvents, e.g., octanol-water, 
where water is always the vehicle. There is no convenient way 
to compare the effects on partition .coeffi cient of such diverse 
vehicles (solvents) as 1-propanol , dim eth ylsulfoxide, dlmethyl-
formamide, propylene glycol, fo rm anlide, and propylene car-
bonate with the eff~ct of water in the wa ter-octanol pair because 
these vehicles are either miscible w ith or at least partially soluble 
in both octano l and water. Yet the vehicles listed above should 
be very important members of any series of vehicles to be tested 
for their effects on dru g diffusion. 
Theoretical partition coeffi cients can also be calculated from 
the solubility para meters [8v(»») of th e 2 phases and the solute drug 
i (8;), and the molar volunle of th e drug (equation 9) (22,23). The 
solubility para meter is a fundam ental therm odynamic property. 
It is defi ned as the squ are root of th e cohesive energy density 
which is equal to the energy of vaporization divided by the molar 
volume /30). T nere are compilations of atomic and group con-
tributions to th e energy of vaporiza tion and th e molar volume 
which can be used to calculate solubil ity parameters where ex-
pe'rimentally determined solubility pa rameters are not available 
[26,27), but the(e are extensi ve compil ations of experimentall y 
determined solubility parameters as well [30,39). The only qu an-
tity th at had been missing from eq uation 9 was a solubility pa-
rameter range for skin. Now, that quantity has been determined 
by Liron and Cohen [31) to be 9.7-10 (cal/cm3)! for fu ll-thickness 
porcine skin. Thus, a calculated partition coeffi cient for the dis-
tribution of any drug between any vehicle and skin is theoreticall y 
accessible . 
The vehicles th at were chosen as model vehicles in the actual 
diffusion cel l experiments were chosen to cover as large a range 
of solu bility parameters as poss ible, yet be representative of ve-
hicles that might be components of formul ations. Theophylline 
was cho~en as the mopel drug because a considerable amount of 
inform ation about its diffusion through biologic membranes was 
already available [24,40), and beca use a topically ava ilable form 
of theophylline may be useful in the treatment of psoriasis (41). 
Suspensions of tr,eophylline were used in all of tbe diffusion eX-
periments because the conclusions reached in the theoretical part 
were based on the partitioning of drug between th e saturated 
solutions, that result from the use of suspensions, and skin. In 
addition , saturated solutions that result from the use of suspen-
sions could be attained and maintained experimentall y during 
these experim ents as a constant much more easily than most other 
set concentrations. Drug lost from the solution by diffusion is 
replenished by dissolution of the suspended drug . This assumes 
that the dissolution of drug i in the vehicle does not become th e 
rate-limiting step in diffusion . ' 
When the diffusion experim ents were run and the flu xes and 
permeability coeffi cients were determined (Ta bles ll , Ill) , it was 
quite cl ea r that thermod ynamic coqtrol would not have predicted 
the results since the flu xes were not constant and they were in-
versely dependent on the concentration of dru g in the vehicles, 
On the o ther hand , when theo reti cal partition coefficients 
[Pq ·v(»») were calculated using equation 9, a parabolic relationship 
between log PCf'v(») and solubility parameter for the vehicles 
[8v(»») was obtained which predicted a minimum va lue for log 
theoretical PCf'v(») (and hence for experim entally determined 
permeability coefficient [K~,'[(» » ) and flu x) for theoph ylline in the 
vehicle having the closest solubil ity param eter to that of theoph-
ylline [8; = 14 (cal/cm3)!] [28] (see Fig 3). When the experimental 
log K;;,i(») values were also plotted against the solubility para;n-
eters of the respective vehicles, a very similar parabolic curve was 
obtained where there was a fairly constant difference betvyeen log 
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Pq 'V(») and log K;;,i (l1) as expected (equation 4), but with 2 ex-
ceptions: octanol and ispropyl myristate had unexpectedl y hig h 
log K~'.i(») values (see Fig 3) . 
There are 2 concepts that resu lt from the relationships between 
the theoretical log PCf'v(»), experimental log K~,i' (» ) and 8v(») which 
are shown in Fig 3. The first concept is that it is possible to 
calculate theoretical partiti on coeffi cients [PCf'v(»)] from known 
group contributions th at accurately describe experimental results 
(or diffusion from vehicles with a wide range of polarity [8V(I1) = 
12-18 (ca l/cm ')!). Once the calculated th eoreti cal partition coef-
fi cients are known for 2 possible drug/vehicle combinations that 
are of interest, and the solubiliti es of the drug in the vehicles are 
determined ex perimentall y, th e flux of th e drug from one vehicle 
relative to the flu x of th e drug from the o ther vehicle can be 
determined merely by multipl ying the theoretical partition coef-
fi cients by the solubilities , The determination of th e absolute flu x 
for th at drug would depend on tb e va lue of tile diffusion coef-
ficient of th e dru g in the sk in (DO and the thickness of the skin 
(h,) (see equation 2) which would have to be determined exper::-
imentally; but it would have to be done for only 1 drug/ vehicle 
combination since we have shown that Df/ h, is a constant for the 
range of vehicle polarities th at would be considered in this treat-
ment. However::, in many cases even a qualitative knowledge of 
relative fluxes may be sufficient to answer relevant clinical qu es-
tions . Thus, although attempts have been made to develop the 
use of partition coefficients calculated from solubility parameters 
o r the solubility para meters of the drugs themselves to predict 
the biologic activity or absorption of dru gs [42-44 J, the present 
resu lts provide a confirmation of the expected parabolic nature 
of the relationship between 8v and experimentall y determined 
K,,-a term directly rel ated to PC. 
The second concept is that , if the value for th e solubility pa-
ram eter for tb e vehicle o r mixture of vehicles is close to that of 
the diffusion membrane, there will be a large increase in the rate 
of diffusion of the dru g from that vehicle or' vehicle mixture 
throu gh the membrane fo r dru gs exhibiting large solubility pa-
rameter values, i.e., polar dru gs [28, 45) . * This concept should 
be useful for predicting which vehicles or combinations of vehicles 
wili cause large increases in rates of diffusion. For example, Cooper 
[36] has shown that 0.5 mole fraction mixtures of propylene 
glycol [8v = 14.8 (cal/cm3)I] in oleic acid [8v = 7.6 (cal/cm 3)!] 
[4p] or oleic alcohol [8v = 8. 1 (cal/cm3)!] [46] cause an approx-
inute 20-fold increase in th e transport rate of salicyclic acid across 
full-thi ckness human abdominal skin compared with the pure 
vehicles. The solubility parameter of these mixtures a're 9.0 and 
9.4 (cal/cm3)!, respectivel y, so that the second concept would 
predi ct the large increases in rate of transport compared with 
either of the pure components that was observed. Some pene-
tration enhancers may also work in a similar way , either alone 
[47) or by combining with other vehicles to form solutions which 
exhibit solubility parameters close to that of skin . On the other 
hand , a mixture of vehicles that resulted in a composite solubility 
parameter which was very close to that of the drug would be 
expected to give a minimum in the rate of transpoi:t of that drug 
compared with ei ther of the pure components. 
So far only one type of vehicle (i.e. , a vehicle with one particular 
type offun ctional gro up, in th e case of octanol, a hydroxy g roup) 
has been tested in each solu bility parameter range SO it is not clear 
whether the un expectedly high experimental K~,i (n ) for octanol-
and , to a lesser degree, isopropyl myristate-are due to those 
particular types of functional groups, that particular solubiljty 
parameter ran ge [9-11 (cal/cm3)1] or a combination of the 2 ef-
fects. However, it is possible, since octanol exhibits a solubility 
parameter that is very similar to that of skin and hence skin should 
exhibit its maximum solubility in octanol [27,28), that octanol 
may be dissolving some part of the barrier function of the skin. 
*Incomplete data from the diffusion of 6-mercaptopurine and 5-fluo-
rouracil (with E. Sherertz) from similar solvents have given similar results, 
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On the other hand, mi croscopic inspection of skin samples treated 
w ith octano l, isopropyl m yristate, dimethylfo rm amide, form-
amide, and propylene g lyco l under the same conditions as the 
d iffusion cell experim ents showed that th e vehicle-trea ted skins 
were not signifi cantly different from skin samples that were not 
treated with any vehicle. 
Rega rdless of w hat the change in th e skin perm ea bility is due 
to w hen it is treated with octano l o r isopropyl myristate, the 
change is not co mpletely reversible after the vehicle is removed 
from the skin. A subsequent treatment o f the skin s with a standard 
drug/ vehicle (theophy ll ine/propy lene g lycol, Tab.le [V) showed 
that signifi cant differen ces in flux of theoph ylline from propylene 
g lyco l existed between skins initially trea ted with theophylline in 
octanol and isop ropyl m yristate and those initiall y treated with 
the standard. [n contrast, very littl e differen ces in flux of the-
o phylline from propylene glycol existed between those skins w hi ch 
had been initially trea ted with theoph ylline in dimeth yl-
form am ide, ethylene g lycol, or form am ide and those initiall y 
treated with the standard. 
Obviously , there is much more work th at needs to be done to 
verify and expand upon the resul ts o f the present wo rk. For 
instance, the effect o f pretreatment w ith vehicles alone on the 
flu x of a subsequent app lication of a solute/vehicle needs to be 
determined for each of the vehicles used. So far on ly isopropyl 
myristate has been evaluated . The flux of theophylline from pro-
pylene g lycol after pretreatment w ith isopropy l myristate alone 
was 1.84 ± 0.23 X 10- 1 m g/cm2 h; or about tw ice as great as 
after pretreatment with theophylline/isopropy l myristate. Gen-
c ["all y, the flux of the vehicles th emselves needs to be evaluated 
under the ex perimental conditions. Also , other vehicles such as 
di methylsulfoxide, mi xtures of vehicles, and, of course, o ther 
dmgs need to be evaluated. 
The allthol's wish to thallk Drs. ) 01111 Pen'ill , S telle Schllllllall , C hris Riley, a/ld 
KCII Piersoll oj the Ullillel'sity oj Florida Jor lIIallY Iz elp}iil disCIIssiolls a/ld CII-
cOllragelll ellt . 
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